학술논문

Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial
Document Type
Article
Source
In: European Journal of Cancer. (European Journal of Cancer, March 2021, 145:1-10)
Subject
Language
English
ISSN
18790852
09598049